Janet M. Dillione's most recent trade in CorMedix Inc was a trade of 10,000 Common Stock done at an average price of $6.9 . Disclosure was reported to the exchange on Jan. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Janet M. Dillione | Director | Sale of securities on an exchange or to another person at price $ 6.88 per share. | 21 Jan 2026 | 10,000 | 38,473 (0%) | 0% | 6.9 | 68,800 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 09 Dec 2025 | 34,000 | 48,473 (0%) | 0% | 12 | 408,000 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.55 per share. | 09 Dec 2025 | 19,000 | 67,473 (0%) | 0% | 9.6 | 181,450 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 19,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 15,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.63 per share. | 09 Dec 2025 | 15,000 | 82,473 (0%) | 0% | 5.6 | 84,450 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 02 Dec 2025 | 46,657 | 48,473 (0%) | 0% | 10 | 466,570 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 19,323 | 5,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. | 02 Dec 2025 | 19,323 | 95,130 (0%) | 0% | 3.6 | 68,597 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.43 per share. | 02 Dec 2025 | 15,124 | 75,807 (0%) | 0% | 4.4 | 66,999 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 15,124 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 12,210 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 02 Dec 2025 | 12,210 | 60,683 (0%) | 0% | 4.0 | 49,206 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Sale of securities on an exchange or to another person at price $ 9.93 per share. | 24 Nov 2025 | 26,343 | 48,473 (0%) | 0% | 9.9 | 261,586 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.85 per share. | 24 Nov 2025 | 8,000 | 56,473 (0%) | 0% | 2.9 | 22,800 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 8,000 | 0 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 7,790 | 12,210 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.03 per share. | 24 Nov 2025 | 7,790 | 64,263 (0%) | 0% | 4.0 | 31,394 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 5,677 | 24,323 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. | 24 Nov 2025 | 5,677 | 74,816 (0%) | 0% | 3.5 | 20,153 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 4,876 | 15,124 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.43 per share. | 24 Nov 2025 | 4,876 | 69,139 (0%) | 0% | 4.4 | 21,601 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Sale of securities on an exchange or to another person at price $ 11.42 per share. | 14 Nov 2025 | 30,000 | 48,473 (0%) | 0% | 11.4 | 342,600 | Common Stock |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 78,473 (0%) | 0% | 0 | Common Stock | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Janet M. Dillione | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy Common Stock) |